Thursday, July 9, 2026

biotech · SLXN

Silexion Therapeutics

News and analysis for Silexion Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

RAMAT GAN, L3, USA HQ
Public company Type
SLXN · NYSE Ticker
Company details
Status
Public
HQ
RAMAT GAN, L3, USA
Programs
0
Drugs
0
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Silexion Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Silexion Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Silexion Therapeutics yet.

Back to company overview →